PubMed

Maculopathy in patients with primary CNS lymphoma treated with chemotherapy in conjunction with blood-brain barrier disruption.

Vicuna-Kojchen J, Frenkel S, Siegal T, Shalom E, Chowers I, Pe'er J.

Br J Ophthalmol. 2008 Feb;92(2):231-5.PMID: 18227203 [PubMed - indexed for MEDLINE]Related articles

Intraarterial chemotherapy and osmotic blood-brain barrier disruption for patients with embryonal and germ cell tumors of the central nervous system.

Jahnke K, Kraemer DF, Knight KR, Fortin D, Bell S, Doolittle ND, Muldoon LL, Neuwelt EA.

Cancer. 2008 Feb 1;112(3):581-8.PMID: 18072268 [PubMed - indexed for MEDLINE]Related articlesFree article

Current status and future of relapsed primary central nervous system lymphoma (PCNSL).

Tyson RM, Siegal T, Doolittle ND, Lacy C, Kraemer DF, Neutwelt EA.

Leuk Lymphoma. 2003 Apr;44(4):627-33.PMID: 12769339 [PubMed - indexed for MEDLINE]Related articles

Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.

Galor A, Ference SJ, Singh AD, Lee MS, Stevens GH, Perez VL, Peereboom DM.

Am J Ophthalmol. 2007 Jul;144(1):45-49.PMID: 17601426 [PubMed - indexed for MEDLINE]Related articles

The potential for complete and durable response in nonglial primary brain tumors in children and young adults with enhanced chemotherapy delivery.

Dahlborg SA, Petrillo A, Crossen JR, Roman-Goldstein S, Doolittle ND, Fuller KH, Neuwelt EA.

Cancer J Sci Am. 1998 Mar-Apr;4(2):110-24.PMID: 9532413 [PubMed - indexed for MEDLINE]Related articles

Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.

Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA, Pe'er J.

Ophthalmology. 2002 Sep;109(9):1709-16.PMID: 12208721 [PubMed - indexed for MEDLINE]Related articles

Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.

Frenkel S, Hendler K, Siegal T, Shalom E, Pe'er J.

Br J Ophthalmol. 2008 Mar;92(3):383-8.PMID: 18303160 [PubMed - indexed for MEDLINE]Related articles

Blood-brain barrier disruption and intra-arterial methotrexate-based therapy for newly diagnosed primary CNS lymphoma: a multi-institutional experience.

Angelov L, Doolittle ND, Kraemer DF, Siegal T, Barnett GH, Peereboom DM, Stevens G, McGregor J, Jahnke K, Lacy CA, Hedrick NA, Shalom E, Ference S, Bell S, Sorenson L, Tyson RM, Haluska M, Neuwelt EA.

J Clin Oncol. 2009 Jul 20;27(21):3503-9. Epub 2009 May 18.PMID: 19451444 [PubMed - indexed for MEDLINE]Related articles

Chemotherapy is effective as early treatment for primary central nervous system lymphoma.

Boiardi A, Silvani A, Pozzi A, Fariselli L, Broggi G, Salmaggi A.

J Neurol. 1999 Jan;246(1):31-7.PMID: 9987711 [PubMed - indexed for MEDLINE]Related articles

Successful treatment of non-Hodgkin's lymphoma of the central nervous system with BMPD chemotherapy followed by radiotherapy.

Korfel A, Thiel E.

Leuk Lymphoma. 1998 Aug;30(5-6):609-17.PMID: 9711923 [PubMed - indexed for MEDLINE]Related articles

Association of total dose intensity of chemotherapy in primary central nervous system lymphoma (human non-acquired immunodeficiency syndrome) and survival.

Kraemer DF, Fortin D, Doolittle ND, Neuwelt EA.

Neurosurgery. 2001 May;48(5):1033-40; discussion 1040-1.PMID: 11334269 [PubMed - indexed for MEDLINE]Related articles

Osmotic blood-brain barrier disruption chemotherapy for diffuse pontine gliomas.

Hall WA, Doolittle ND, Daman M, Bruns PK, Muldoon L, Fortin D, Neuwelt EA.

J Neurooncol. 2006 May;77(3):279-84. Epub 2005 Nov 29.PMID: 16314949 [PubMed - indexed for MEDLINE]Related articles

Intrathecal chemotherapy for recurrent central nervous system intraocular lymphoma.

Mason JO, Fischer DH.

Ophthalmology. 2003 Jun;110(6):1241-4.PMID: 12799254 [PubMed - indexed for MEDLINE]Related articles

Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients.

Freilich RJ, Delattre JY, Monjour A, DeAngelis LM.

Neurology. 1996 Feb;46(2):435-9.PMID: 8614508 [PubMed - indexed for MEDLINE]Related articles

Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma.

Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA.

Arch Ophthalmol. 1997 Sep;115(9):1152-6.PMID: 9298056 [PubMed - indexed for MEDLINE]Related articles

Cognitive status and quality of life after treatment for primary CNS lymphoma.

Harder H, Holtel H, Bromberg JE, Poortmans P, Haaxma-Reiche H, Kluin-Nelemans HC, Menten J, van den Bent MJ.

Neurology. 2004 Feb 24;62(4):544-7.PMID: 14981168 [PubMed - indexed for MEDLINE]Related articles

Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment.

Hormigo A, Abrey L, Heinemann MH, DeAngelis LM.

Br J Haematol. 2004 Jul;126(2):202-8.PMID: 15238140 [PubMed - indexed for MEDLINE]Related articles

Cognitive outcomes and long-term follow-up results after enhanced chemotherapy delivery for primary central nervous system lymphoma.

McAllister LD, Doolittle ND, Guastadisegni PE, Kraemer DF, Lacy CA, Crossen JR, Neuwelt EA.

Neurosurgery. 2000 Jan;46(1):51-60; discussion 60-1.PMID: 10626935 [PubMed - indexed for MEDLINE]Related articles

Enhanced chemotherapy delivery by intraarterial infusion and blood-brain barrier disruption in the treatment of cerebral metastasis.

Fortin D, Gendron C, Boudrias M, Garant MP.

Cancer. 2007 Feb 15;109(4):751-60.PMID: 17211866 [PubMed - indexed for MEDLINE]Related articlesFree article

Relevance of intraocular involvement in the management of primary central nervous system lymphomas.

Ferreri AJ, Blay JY, Reni M, Pasini F, Gubkin A, Tirelli U, Calderoni A, Zucca E, Cortelazzo S, Chassagne C, Tinguely M, Borisch B, Berger F, Ponzoni M, Cavalli F; International Extranodal Lymphoma Study Group (IELSG).

Ann Oncol. 2002 Apr;13(4):531-8.PMID: 12056702 [PubMed - indexed for MEDLINE]Related articlesFree article